Global Biosimilars Market Insights, Forecast to 2029

Global Biosimilars Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Biosimilars Product Introduction
1.2 Market by Type
1.2.1 Global Biosimilars Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
1.2.3 Recombinant Glycosylated Proteins
1.3 Market by Application
1.3.1 Global Biosimilars Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Oncology
1.3.3 Blood Disorders
1.3.4 Growth Hormonal Deficiency
1.3.5 Chronic and Autoimmune Disorders
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biosimilars Sales Estimates and Forecasts 2018-2029
2.2 Global Biosimilars Revenue by Region
2.2.1 Global Biosimilars Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Biosimilars Revenue by Region (2018-2023)
2.2.3 Global Biosimilars Revenue by Region (2024-2029)
2.2.4 Global Biosimilars Revenue Market Share by Region (2018-2029)
2.3 Global Biosimilars Sales Estimates and Forecasts 2018-2029
2.4 Global Biosimilars Sales by Region
2.4.1 Global Biosimilars Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Biosimilars Sales by Region (2018-2023)
2.4.3 Global Biosimilars Sales by Region (2024-2029)
2.4.4 Global Biosimilars Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Biosimilars Sales by Manufacturers
3.1.1 Global Biosimilars Sales by Manufacturers (2018-2023)
3.1.2 Global Biosimilars Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biosimilars in 2022
3.2 Global Biosimilars Revenue by Manufacturers
3.2.1 Global Biosimilars Revenue by Manufacturers (2018-2023)
3.2.2 Global Biosimilars Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Biosimilars Revenue in 2022
3.3 Global Key Players of Biosimilars, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Biosimilars Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Biosimilars, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Biosimilars, Product Offered and Application
3.8 Global Key Manufacturers of Biosimilars, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Biosimilars Sales by Type
4.1.1 Global Biosimilars Historical Sales by Type (2018-2023)
4.1.2 Global Biosimilars Forecasted Sales by Type (2024-2029)
4.1.3 Global Biosimilars Sales Market Share by Type (2018-2029)
4.2 Global Biosimilars Revenue by Type
4.2.1 Global Biosimilars Historical Revenue by Type (2018-2023)
4.2.2 Global Biosimilars Forecasted Revenue by Type (2024-2029)
4.2.3 Global Biosimilars Revenue Market Share by Type (2018-2029)
4.3 Global Biosimilars Price by Type
4.3.1 Global Biosimilars Price by Type (2018-2023)
4.3.2 Global Biosimilars Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Biosimilars Sales by Application
5.1.1 Global Biosimilars Historical Sales by Application (2018-2023)
5.1.2 Global Biosimilars Forecasted Sales by Application (2024-2029)
5.1.3 Global Biosimilars Sales Market Share by Application (2018-2029)
5.2 Global Biosimilars Revenue by Application
5.2.1 Global Biosimilars Historical Revenue by Application (2018-2023)
5.2.2 Global Biosimilars Forecasted Revenue by Application (2024-2029)
5.2.3 Global Biosimilars Revenue Market Share by Application (2018-2029)
5.3 Global Biosimilars Price by Application
5.3.1 Global Biosimilars Price by Application (2018-2023)
5.3.2 Global Biosimilars Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Biosimilars Market Size by Type
6.1.1 US & Canada Biosimilars Sales by Type (2018-2029)
6.1.2 US & Canada Biosimilars Revenue by Type (2018-2029)
6.2 US & Canada Biosimilars Market Size by Application
6.2.1 US & Canada Biosimilars Sales by Application (2018-2029)
6.2.2 US & Canada Biosimilars Revenue by Application (2018-2029)
6.3 US & Canada Biosimilars Market Size by Country
6.3.1 US & Canada Biosimilars Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Biosimilars Sales by Country (2018-2029)
6.3.3 US & Canada Biosimilars Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Biosimilars Market Size by Type
7.1.1 Europe Biosimilars Sales by Type (2018-2029)
7.1.2 Europe Biosimilars Revenue by Type (2018-2029)
7.2 Europe Biosimilars Market Size by Application
7.2.1 Europe Biosimilars Sales by Application (2018-2029)
7.2.2 Europe Biosimilars Revenue by Application (2018-2029)
7.3 Europe Biosimilars Market Size by Country
7.3.1 Europe Biosimilars Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Biosimilars Sales by Country (2018-2029)
7.3.3 Europe Biosimilars Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Biosimilars Market Size
8.1.1 China Biosimilars Sales (2018-2029)
8.1.2 China Biosimilars Revenue (2018-2029)
8.2 China Biosimilars Market Size by Application
8.2.1 China Biosimilars Sales by Application (2018-2029)
8.2.2 China Biosimilars Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Biosimilars Market Size by Type
9.1.1 Asia Biosimilars Sales by Type (2018-2029)
9.1.2 Asia Biosimilars Revenue by Type (2018-2029)
9.2 Asia Biosimilars Market Size by Application
9.2.1 Asia Biosimilars Sales by Application (2018-2029)
9.2.2 Asia Biosimilars Revenue by Application (2018-2029)
9.3 Asia Biosimilars Sales by Region
9.3.1 Asia Biosimilars Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Biosimilars Revenue by Region (2018-2029)
9.3.3 Asia Biosimilars Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Biosimilars Market Size by Type
10.1.1 Middle East, Africa and Latin America Biosimilars Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Biosimilars Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Biosimilars Market Size by Application
10.2.1 Middle East, Africa and Latin America Biosimilars Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Biosimilars Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Biosimilars Sales by Country
10.3.1 Middle East, Africa and Latin America Biosimilars Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Biosimilars Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Biosimilars Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Pfizer Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Overview
11.2.3 Novartis Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Novartis Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis Recent Developments
11.3 Biocon
11.3.1 Biocon Company Information
11.3.2 Biocon Overview
11.3.3 Biocon Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Biocon Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Biocon Recent Developments
11.4 Biogen
11.4.1 Biogen Company Information
11.4.2 Biogen Overview
11.4.3 Biogen Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Biogen Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Biogen Recent Developments
11.5 Fresenius Kabi AG
11.5.1 Fresenius Kabi AG Company Information
11.5.2 Fresenius Kabi AG Overview
11.5.3 Fresenius Kabi AG Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Fresenius Kabi AG Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Fresenius Kabi AG Recent Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Information
11.6.2 Boehringer Ingelheim Overview
11.6.3 Boehringer Ingelheim Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Boehringer Ingelheim Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Boehringer Ingelheim Recent Developments
11.7 Merck KgaA
11.7.1 Merck KgaA Company Information
11.7.2 Merck KgaA Overview
11.7.3 Merck KgaA Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Merck KgaA Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck KgaA Recent Developments
11.8 Mylan
11.8.1 Mylan Company Information
11.8.2 Mylan Overview
11.8.3 Mylan Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Mylan Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Mylan Recent Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Company Information
11.9.2 Eli Lilly Overview
11.9.3 Eli Lilly Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Eli Lilly Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Eli Lilly Recent Developments
11.10 Teva Pharmaceutical
11.10.1 Teva Pharmaceutical Company Information
11.10.2 Teva Pharmaceutical Overview
11.10.3 Teva Pharmaceutical Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Teva Pharmaceutical Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Teva Pharmaceutical Recent Developments
11.11 Dr. Reddy's Laboratories
11.11.1 Dr. Reddy's Laboratories Company Information
11.11.2 Dr. Reddy's Laboratories Overview
11.11.3 Dr. Reddy's Laboratories Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Dr. Reddy's Laboratories Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Dr. Reddy's Laboratories Recent Developments
11.12 Amgen
11.12.1 Amgen Company Information
11.12.2 Amgen Overview
11.12.3 Amgen Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Amgen Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Amgen Recent Developments
11.13 Celltrion
11.13.1 Celltrion Company Information
11.13.2 Celltrion Overview
11.13.3 Celltrion Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Celltrion Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Celltrion Recent Developments
11.14 Samsung Biologics
11.14.1 Samsung Biologics Company Information
11.14.2 Samsung Biologics Overview
11.14.3 Samsung Biologics Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 Samsung Biologics Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Samsung Biologics Recent Developments
11.15 Roche
11.15.1 Roche Company Information
11.15.2 Roche Overview
11.15.3 Roche Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.15.4 Roche Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Roche Recent Developments
11.16 Probiomed
11.16.1 Probiomed Company Information
11.16.2 Probiomed Overview
11.16.3 Probiomed Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.16.4 Probiomed Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Probiomed Recent Developments
11.17 Apotex
11.17.1 Apotex Company Information
11.17.2 Apotex Overview
11.17.3 Apotex Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.17.4 Apotex Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Apotex Recent Developments
11.18 Chong Kun Dang
11.18.1 Chong Kun Dang Company Information
11.18.2 Chong Kun Dang Overview
11.18.3 Chong Kun Dang Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.18.4 Chong Kun Dang Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Chong Kun Dang Recent Developments
11.19 JCR Pharmaceuticals
11.19.1 JCR Pharmaceuticals Company Information
11.19.2 JCR Pharmaceuticals Overview
11.19.3 JCR Pharmaceuticals Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.19.4 JCR Pharmaceuticals Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 JCR Pharmaceuticals Recent Developments
11.20 Gan & Lee Pharmaceuticals
11.20.1 Gan & Lee Pharmaceuticals Company Information
11.20.2 Gan & Lee Pharmaceuticals Overview
11.20.3 Gan & Lee Pharmaceuticals Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.20.4 Gan & Lee Pharmaceuticals Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Gan & Lee Pharmaceuticals Recent Developments
11.21 Gedeon Richter
11.21.1 Gedeon Richter Company Information
11.21.2 Gedeon Richter Overview
11.21.3 Gedeon Richter Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.21.4 Gedeon Richter Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Gedeon Richter Recent Developments
11.22 Biocad
11.22.1 Biocad Company Information
11.22.2 Biocad Overview
11.22.3 Biocad Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.22.4 Biocad Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Biocad Recent Developments
11.23 Coherus Bioscience
11.23.1 Coherus Bioscience Company Information
11.23.2 Coherus Bioscience Overview
11.23.3 Coherus Bioscience Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.23.4 Coherus Bioscience Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Coherus Bioscience Recent Developments
11.24 Stada Arzneimittel AG
11.24.1 Stada Arzneimittel AG Company Information
11.24.2 Stada Arzneimittel AG Overview
11.24.3 Stada Arzneimittel AG Biosimilars Sales, Price, Revenue and Gross Margin (2018-2023)
11.24.4 Stada Arzneimittel AG Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 Stada Arzneimittel AG Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Biosimilars Industry Chain Analysis
12.2 Biosimilars Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Biosimilars Production Mode & Process
12.4 Biosimilars Sales and Marketing
12.4.1 Biosimilars Sales Channels
12.4.2 Biosimilars Distributors
12.5 Biosimilars Customers
13 Market Dynamics
13.1 Biosimilars Industry Trends
13.2 Biosimilars Market Drivers
13.3 Biosimilars Market Challenges
13.4 Biosimilars Market Restraints
14 Key Findings in The Global Biosimilars Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Biosimilars Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
Table 3. Major Manufacturers of Recombinant Glycosylated Proteins
Table 4. Global Biosimilars Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Biosimilars Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Biosimilars Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Biosimilars Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Biosimilars Revenue Market Share by Region (2018-2023)
Table 9. Global Biosimilars Revenue Market Share by Region (2024-2029)
Table 10. Global Biosimilars Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Biosimilars Sales by Region (2018-2023) & (K Units)
Table 12. Global Biosimilars Sales by Region (2024-2029) & (K Units)
Table 13. Global Biosimilars Sales Market Share by Region (2018-2023)
Table 14. Global Biosimilars Sales Market Share by Region (2024-2029)
Table 15. Global Biosimilars Sales by Manufacturers (2018-2023) & (K Units)
Table 16. Global Biosimilars Sales Share by Manufacturers (2018-2023)
Table 17. Global Biosimilars Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Biosimilars Revenue Share by Manufacturers (2018-2023)
Table 19. Global Key Players of Biosimilars, Industry Ranking, 2021 VS 2022 VS 2023
Table 20. Biosimilars Price by Manufacturers 2018-2023 (USD/Unit)
Table 21. Global Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Biosimilars by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilars as of 2022)
Table 23. Global Key Manufacturers of Biosimilars, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Biosimilars, Product Offered and Application
Table 25. Global Key Manufacturers of Biosimilars, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Biosimilars Sales by Type (2018-2023) & (K Units)
Table 28. Global Biosimilars Sales by Type (2024-2029) & (K Units)
Table 29. Global Biosimilars Sales Share by Type (2018-2023)
Table 30. Global Biosimilars Sales Share by Type (2024-2029)
Table 31. Global Biosimilars Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Biosimilars Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Biosimilars Revenue Share by Type (2018-2023)
Table 34. Global Biosimilars Revenue Share by Type (2024-2029)
Table 35. Biosimilars Price by Type (2018-2023) & (USD/Unit)
Table 36. Global Biosimilars Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Biosimilars Sales by Application (2018-2023) & (K Units)
Table 38. Global Biosimilars Sales by Application (2024-2029) & (K Units)
Table 39. Global Biosimilars Sales Share by Application (2018-2023)
Table 40. Global Biosimilars Sales Share by Application (2024-2029)
Table 41. Global Biosimilars Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Biosimilars Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Biosimilars Revenue Share by Application (2018-2023)
Table 44. Global Biosimilars Revenue Share by Application (2024-2029)
Table 45. Biosimilars Price by Application (2018-2023) & (USD/Unit)
Table 46. Global Biosimilars Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Biosimilars Sales by Type (2018-2023) & (K Units)
Table 48. US & Canada Biosimilars Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Biosimilars Revenue by Type (2018-2023) & (US$ Million)
Table 50. US & Canada Biosimilars Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Biosimilars Sales by Application (2018-2023) & (K Units)
Table 52. US & Canada Biosimilars Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Biosimilars Revenue by Application (2018-2023) & (US$ Million)
Table 54. US & Canada Biosimilars Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Biosimilars Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Biosimilars Revenue by Country (2018-2023) & (US$ Million)
Table 57. US & Canada Biosimilars Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Biosimilars Sales by Country (2018-2023) & (K Units)
Table 59. US & Canada Biosimilars Sales by Country (2024-2029) & (K Units)
Table 60. Europe Biosimilars Sales by Type (2018-2023) & (K Units)
Table 61. Europe Biosimilars Sales by Type (2024-2029) & (K Units)
Table 62. Europe Biosimilars Revenue by Type (2018-2023) & (US$ Million)
Table 63. Europe Biosimilars Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Biosimilars Sales by Application (2018-2023) & (K Units)
Table 65. Europe Biosimilars Sales by Application (2024-2029) & (K Units)
Table 66. Europe Biosimilars Revenue by Application (2018-2023) & (US$ Million)
Table 67. Europe Biosimilars Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Biosimilars Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Biosimilars Revenue by Country (2018-2023) & (US$ Million)
Table 70. Europe Biosimilars Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Biosimilars Sales by Country (2018-2023) & (K Units)
Table 72. Europe Biosimilars Sales by Country (2024-2029) & (K Units)
Table 73. China Biosimilars Sales by Type (2018-2023) & (K Units)
Table 74. China Biosimilars Sales by Type (2024-2029) & (K Units)
Table 75. China Biosimilars Revenue by Type (2018-2023) & (US$ Million)
Table 76. China Biosimilars Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Biosimilars Sales by Application (2018-2023) & (K Units)
Table 78. China Biosimilars Sales by Application (2024-2029) & (K Units)
Table 79. China Biosimilars Revenue by Application (2018-2023) & (US$ Million)
Table 80. China Biosimilars Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Biosimilars Sales by Type (2018-2023) & (K Units)
Table 82. Asia Biosimilars Sales by Type (2024-2029) & (K Units)
Table 83. Asia Biosimilars Revenue by Type (2018-2023) & (US$ Million)
Table 84. Asia Biosimilars Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Biosimilars Sales by Application (2018-2023) & (K Units)
Table 86. Asia Biosimilars Sales by Application (2024-2029) & (K Units)
Table 87. Asia Biosimilars Revenue by Application (2018-2023) & (US$ Million)
Table 88. Asia Biosimilars Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Biosimilars Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Biosimilars Revenue by Region (2018-2023) & (US$ Million)
Table 91. Asia Biosimilars Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Biosimilars Sales by Region (2018-2023) & (K Units)
Table 93. Asia Biosimilars Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Biosimilars Sales by Type (2018-2023) & (K Units)
Table 95. Middle East, Africa and Latin America Biosimilars Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Biosimilars Revenue by Type (2018-2023) & (US$ Million)
Table 97. Middle East, Africa and Latin America Biosimilars Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Biosimilars Sales by Application (2018-2023) & (K Units)
Table 99. Middle East, Africa and Latin America Biosimilars Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Biosimilars Revenue by Application (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Biosimilars Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Biosimilars Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Biosimilars Revenue by Country (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Biosimilars Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Biosimilars Sales by Country (2018-2023) & (K Units)
Table 106. Middle East, Africa and Latin America Biosimilars Sales by Country (2024-2029) & (K Units)
Table 107. Pfizer Company Information
Table 108. Pfizer Description and Major Businesses
Table 109. Pfizer Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 110. Pfizer Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Pfizer Recent Developments
Table 112. Novartis Company Information
Table 113. Novartis Description and Major Businesses
Table 114. Novartis Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 115. Novartis Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Novartis Recent Developments
Table 117. Biocon Company Information
Table 118. Biocon Description and Major Businesses
Table 119. Biocon Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 120. Biocon Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Biocon Recent Developments
Table 122. Biogen Company Information
Table 123. Biogen Description and Major Businesses
Table 124. Biogen Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 125. Biogen Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Biogen Recent Developments
Table 127. Fresenius Kabi AG Company Information
Table 128. Fresenius Kabi AG Description and Major Businesses
Table 129. Fresenius Kabi AG Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 130. Fresenius Kabi AG Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Fresenius Kabi AG Recent Developments
Table 132. Boehringer Ingelheim Company Information
Table 133. Boehringer Ingelheim Description and Major Businesses
Table 134. Boehringer Ingelheim Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 135. Boehringer Ingelheim Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Boehringer Ingelheim Recent Developments
Table 137. Merck KgaA Company Information
Table 138. Merck KgaA Description and Major Businesses
Table 139. Merck KgaA Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 140. Merck KgaA Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Merck KgaA Recent Developments
Table 142. Mylan Company Information
Table 143. Mylan Description and Major Businesses
Table 144. Mylan Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 145. Mylan Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Mylan Recent Developments
Table 147. Eli Lilly Company Information
Table 148. Eli Lilly Description and Major Businesses
Table 149. Eli Lilly Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 150. Eli Lilly Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Eli Lilly Recent Developments
Table 152. Teva Pharmaceutical Company Information
Table 153. Teva Pharmaceutical Description and Major Businesses
Table 154. Teva Pharmaceutical Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 155. Teva Pharmaceutical Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Teva Pharmaceutical Recent Developments
Table 157. Dr. Reddy's Laboratories Company Information
Table 158. Dr. Reddy's Laboratories Description and Major Businesses
Table 159. Dr. Reddy's Laboratories Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 160. Dr. Reddy's Laboratories Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Dr. Reddy's Laboratories Recent Developments
Table 162. Amgen Company Information
Table 163. Amgen Description and Major Businesses
Table 164. Amgen Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 165. Amgen Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Amgen Recent Developments
Table 167. Celltrion Company Information
Table 168. Celltrion Description and Major Businesses
Table 169. Celltrion Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 170. Celltrion Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Celltrion Recent Developments
Table 172. Samsung Biologics Company Information
Table 173. Samsung Biologics Description and Major Businesses
Table 174. Samsung Biologics Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 175. Samsung Biologics Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Samsung Biologics Recent Developments
Table 177. Roche Company Information
Table 178. Roche Description and Major Businesses
Table 179. Roche Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 180. Roche Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Roche Recent Developments
Table 182. Probiomed Company Information
Table 183. Probiomed Description and Major Businesses
Table 184. Probiomed Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 185. Probiomed Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Probiomed Re

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biologics and Biosimilars Market Insights, Forecast to 2029

Published: 22-Sep-2023        Price: US 4900 Onwards        Pages: 115

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactu......

Global Biologics and Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Sep-2023        Price: US 3380 Onwards        Pages: 126

Market Overview of Global Biologics and Biosimilars market: According to our latest research, the global Biologics and Biosimilars market looks promising in the next 5 years. As of 2022, the global Biologics and Biosimilars market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Biosimilars are biomedical products that are almost identical to the original products made by different companies. ......

Global Biosimilar Drug Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 01-Aug-2023        Price: US 3260 Onwards        Pages: 125

Biosimilar therapy is defined as a therapy that is highly similar to approved biopharmaceuticals. They are made by converting biopharmaceuticals made from living cells in the laboratory into large-scale production molecules. This is quite different from the general treatment method, which is identical to the reference small molecule drug. The reason behind this is that it is impossible to make a copy of the same biologic drug. The Biosimilar Drug market revenue was 16199.84 Million USD in......

Global Oncology Biosimilars Market Insights, Forecast to 2029

Published: 07-Jul-2023        Price: US 4900 Onwards        Pages: 110

Biosimilar is the identical copy of oncology biologics used for the treatment of cancer and officially approved for the treatment of cancer. These molecules are cost-effective, efficient, and have the same ability as biologics. These molecules are easy to manufacture as compared to biologics and can only be manufactured after patent expiry. Earlier there were various patented biologics available in the market but nowadays most of the patents have expired and few are on the verge of patent expiry......

Global Adalimumab Biosimilar Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 04-Jul-2023        Price: US 3260 Onwards        Pages: 125

Adalimumab was a first fully humanized monoclonal antibody approved by US Food and Drug Administration (FDA) in 2002. Clinical efficacy and safety of adalimumab has been assessed in various trials in rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, Crohn's Disease, and ulcerative colitis. It is one of the major sales success among biological and still one of the greatest blockbuster amongst monoclonal antibodies. The Adalimumab Biosimilar market revenue was 2......

Global Follow-On-Biologics Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 22-Jun-2023        Price: US 3260 Onwards        Pages: 114

The Follow-On-Biologics market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Follow-On-Biologics industry, and breaks down according to the type, application, and consumption area of Follow-On-Biologics. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describe......

Biosimilars Market by Drug Class (Drug Class (Monoclonal Antibodies (Adalimumab, Infliximab, Rituximab, Trastuzumab), Insulin, Erythropoietin, Anticoagulants. rhGH), Indication, Region - Global Forecast to 2028

Published: 15-Jun-2023        Price: US 4950 Onwards        Pages: 306

“The biosimilars market is projected to grow at a CAGR of 17.8% during the forecast of 2023-2028” The global biosimilars market size is projected to reach USD 66.9 billion by 2028 from USD 29.4 billion in 2023, at a CAGR of 17.8% during the forecast period. Factors such as regulatory approvals, favorable reimbursement policies, rising demand for cost effective biosimilars is driving the market growth. “The monoclonal antibodies produc......

Global Biosimilars-On-Biologics Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 06-Jun-2023        Price: US 3260 Onwards        Pages: 130

The Biosimilars-On-Biologics market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Biosimilars-On-Biologics industry, and breaks down according to the type, application, and consumption area of Biosimilars-On-Biologics. The report also introduces players in the industry from the perspective of the industry chain and marketing cha......

Global Biosimilars Partnering Terms and Agreements 2010 to 2023

Published: 01-Jun-2023        Price: US 3995 Onwards        Pages: 150

The Global Biosimilars Partnering Terms and Agreements 2010 to 2023 report provides comprehensive understanding and unprecedented access to the biosimilars partnering deals and agreements entered into by the worlds leading healthcare companies......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs